Attached files
file | filename |
---|---|
EX-32.2 - EX-32.2 - UNITED STATES CELLULAR CORP | usmexhibit32_2.htm |
EX-32.1 - EX-32.1 - UNITED STATES CELLULAR CORP | usmexhibit32_1.htm |
EX-31.2 - EX-31.2 - UNITED STATES CELLULAR CORP | usmexhibit31_2.htm |
EX-31.1 - EX-31.1 - UNITED STATES CELLULAR CORP | usmexhibit31_1.htm |
EX-23.2 - EX-23.2 - UNITED STATES CELLULAR CORP | usmexhibit23_2.htm |
EX-23.1 - EX-23.1 - UNITED STATES CELLULAR CORP | usmexhibit23_1.htm |
EX-21 - EX-21 - UNITED STATES CELLULAR CORP | usmexhibit21.htm |
EX-13 - EX-13 - UNITED STATES CELLULAR CORP | usmexhibit13.htm |
EX-10.2 - EX-10.2 - UNITED STATES CELLULAR CORP | usmexhibit10_2.htm |
10-K - 10-K - UNITED STATES CELLULAR CORP | usm10k.htm |
UNITED STATES CELLULAR CORPORATION
RATIO OF EARNINGS TO FIXED CHARGES
2017 |
|
2016 |
|
2015 |
|
2014 |
|
2013 |
||||||||
(Dollars in millions) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EARNINGS: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Income (loss) before income taxes1 |
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|||||||
Add (deduct): |
|
|
|
|
|
|
|
|
|
|||||||
|
Equity in earnings of unconsolidated entities |
|
|
|
|
|
|
|
|
|
||||||
|
Distributions from unconsolidated entities |
|
|
|
|
|
|
|
|
|
||||||
|
Amortization of capitalized interest |
|
|
|
|
|
|
|
|
|
||||||
|
Income attributable to noncontrolling interests in subsidiaries that do not have fixed charges |
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Add fixed charges: |
|
|
|
|
|
|
|
|
|
|||||||
|
Consolidated interest expense2 |
|
|
|
|
|
|
|
|
|
||||||
|
Interest portion (1/3) of consolidated rent expense |
|
|
|
|
|
|
|
|
|
||||||
|
|
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|||||
FIXED CHARGES: |
|
|
|
|
|
|
|
|
|
|||||||
|
Consolidated interest expense2 |
$ |
|
$ |
|
$ |
|
$ |
|
$ |
||||||
|
Capitalized interest |
|
|
|
|
|
|
|
|
|
||||||
|
Interest portion (1/3) of consolidated rent expense |
|
|
|
|
|
|
|
|
|
||||||
|
|
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
RATIO OF EARNINGS TO FIXED CHARGES |
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
Includes non-cash charges related to losses on impairment of $370 million in 2017. |
|||||||||||||||
|
Includes gain on sale of business and other exit costs, net of $1 million, $114 million, $33 million and $247 million in 2017, 2015, 2014 and 2013, respectively. |
|||||||||||||||
|
Includes gain on license sales and exchanges, net of $22 million, $19 million, $147 million, $113 million and $255 million in 2017, 2016, 2015, 2014 and 2013, respectively. |
|||||||||||||||
|
Includes gain on investments of $19 million in 2013. |
|||||||||||||||
2 |
Interest expense on income tax contingencies is not included in fixed charges. |
|||||||||||||||
* |
Earnings in 2017 and 2014 were inadequate to cover fixed charges by $269 million and $79 million, respectively. |